0001022079-16-000263.txt : 20160516 0001022079-16-000263.hdr.sgml : 20160516 20160516162525 ACCESSION NUMBER: 0001022079-16-000263 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160512 FILED AS OF DATE: 20160516 DATE AS OF CHANGE: 20160516 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRITELL JENNE K CENTRAL INDEX KEY: 0001142318 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 161654244 MAIL ADDRESS: STREET 1: 100 FIRST STAMFORD PLACE STREET 2: SUITE 700 CITY: STAMFORD STATE: CT ZIP: 06902 4 1 wf-form4_146343031282306.xml FORM 4 X0306 4 2016-05-12 0 0001022079 QUEST DIAGNOSTICS INC DGX 0001142318 BRITELL JENNE K C/O QUEST DIAGNOSTICS 3 GIRALDA FARMS MADISON NJ 07940 1 0 0 0 Common Stock 2016-05-12 4 M 0 8000 51.55 A 19655 I by Trust Common Stock 2016-05-12 4 S 0 8000 75.682 D 11655 I by Trust Common Stock 6025 D Stock Options (Right to Buy) 51.55 2016-05-12 4 M 0 8000 51.55 D 2019-05-14 Common Stock 8000.0 0 I by Trust This transaction was executed in multiple trades at prices ranging from $75.67 to $75.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provideupon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Shares reported as directly held on reporting person's previous Form 4 filing were subsequently transferred to a family trust in a transaction exempt from Section 16 under Rule 16a-13. The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. The options vested in three equal annual installments beginning with the first on May 14, 2010, the second on May 14, 2011 and the final on May 14, 2012. /s/William J. O'Shaughnessy, Jr., Attorney in Fact for Jenne K. Britell 2016-05-16